Address
Email address
Phone number
https://genecode.comGenecode - Developing novel
disease modifying drugsOur mission is a simple question we ask ourselves — can we slow down or stop neurodegeneration when treating chronic neurological diseases?
Name
GeneCode AS
Registry code
10362550
VAT number
EE101059031
Type
AS - Joint Stock Company
Status
Registered
Foundation date
15.01.1998 (27)
Financial year
01.01-31.12
Capital
75 600.00 €
Activity
72111 - Research and experimental development on biotechnology
-
-
-
-
-
-
-
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| AnsonBaer Nordic OÜ 11365489 | 40% - 30 240.00 EUR | - | - | Shareholder |
| MPPS Investeeringud OÜ 10634869 | 25% - 18 900.00 EUR | - | - | Shareholder |
| Paavo Pilv
| - | Board member | - | |
| Hendrik Hindov
| - | - | - | Board member |
| Mart Saarma
| - | - | - | Board member |
| Mehis Pilv
| - | - | - | Board member |
| Thomas Björn Waldin
| - | - | - | Board member |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| CERE Code AS 11553038 | - | - | - | Founder |
| OliCode AS 11386741 | - | - | - | Founder |
| NeuronCode AS 11386497 | - | - | - | Founder |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q4 | 79 457.86 € | 16 937.53 € | 19 148.04 € | 3 |
| 2024 Q3 | 139 719.23 € | 7 875.17 € | 15 908.1 € | 3 |
| 2024 Q2 | 124 664.7 € | 4 342.74 € | 9 428.22 € | 2 |
| 2024 Q1 | 77 554.45 € | - | 10 422.38 € | 2 |
| 2023 Q4 | 20 549.53 € | 8 807.33 € | 11 947.89 € | 3 |
| 2023 Q3 | 188 978.21 € | 9 883.78 € | 12 072.96 € | 3 |
| 2023 Q2 | 266 351.85 € | 8 723.06 € | 11 947.89 € | 3 |
| 2023 Q1 | 376 039.19 € | 10 694.12 € | 11 842.01 € | 3 |
| 2022 Q4 | 267 047.88 € | - | 10 880.91 € | 3 |
| 2022 Q3 | 314 082.38 € | 9 152.94 € | 12 302.05 € | 3 |
| 2022 Q2 | 636 876.6 € | - | 5 847.23 € | 3 |
| 2022 Q1 | 4 604.15 € | 1 663.32 € | 5 461.82 € | 3 |
| 2021 Q4 | 3 162.83 € | - | - | - |
| 2021 Q3 | - | - | - | - |
| 2021 Q2 | 4 910 € | - | - | - |
| 2021 Q1 | 6 636.19 € | - | - | - |
| 2020 Q4 | 12 606.41 € | - | - | - |
| 2020 Q3 | - | - | - | - |
| 2020 Q2 | 4 250 € | 817.06 € | - | - |
| 2020 Q1 | 1 396.57 € | - | - | - |
